Nila Kartika Wati

Beyond the Mammogram: Navigating Breast Cancer Risk with the Tyrer-Cuzick Model

• Survivorship and Post-Treatment

Beyond the Mammogram: Navigating Breast Cancer Risk with the Tyrer-Cuzick Model

Nila Kartika Wati September 13, 2026

Medical Disclaimer: This information is intended for educational purposes only and does not constitute medical advice, diagnosis,...

Read More Read more about Beyond the Mammogram: Navigating Breast Cancer Risk with the Tyrer-Cuzick Model

Johnson & Johnson Advances Vision Innovation: CE Mark Secured for ACUVUE OASYS MAX 2-Week Lenses

• Treatment Innovations

Johnson & Johnson Advances Vision Innovation: CE Mark Secured for ACUVUE OASYS MAX 2-Week Lenses

Nila Kartika Wati September 12, 2026

Johnson & Johnson (J&J) has marked a significant milestone in the evolution of vision correction, securing the...

Read More Read more about Johnson & Johnson Advances Vision Innovation: CE Mark Secured for ACUVUE OASYS MAX 2-Week Lenses

From Soil to Sustainable Synthesis: The Genetic Revolution in Perennial Grasses

• Genomics and Precision Medicine

From Soil to Sustainable Synthesis: The Genetic Revolution in Perennial Grasses

Nila Kartika Wati September 11, 2026

As the global industrial landscape faces an existential reckoning regarding its reliance on fossil fuels, a quiet...

Read More Read more about From Soil to Sustainable Synthesis: The Genetic Revolution in Perennial Grasses

AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of Interval Breast Cancers

• Medical Research and Clinical Trials

AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of Interval Breast Cancers

Nila Kartika Wati September 10, 2026

LOS ANGELES, CA – A groundbreaking study spearheaded by investigators at the UCLA Health Jonsson Comprehensive Cancer...

Read More Read more about AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of Interval Breast Cancers

Strengthening Global Health Architecture: A Strategic Dialogue Between Spain and the World Health Organization

• Breast Cancer Prevention and Lifestyle

Strengthening Global Health Architecture: A Strategic Dialogue Between Spain and the World Health Organization

Nila Kartika Wati September 10, 2026

Introduction On April 23 and 24, 2024, the World Health Organization (WHO) headquarters in Geneva became the...

Read More Read more about Strengthening Global Health Architecture: A Strategic Dialogue Between Spain and the World Health Organization

The Frontier of Genetic Medicine: Decoding the ‘In Vivo’ vs. ‘Ex Vivo’ Divide

• Genomics and Precision Medicine

The Frontier of Genetic Medicine: Decoding the ‘In Vivo’ vs. ‘Ex Vivo’ Divide

Nila Kartika Wati September 10, 2026

The landscape of modern medicine is currently undergoing its most significant transformation since the discovery of antibiotics....

Read More Read more about The Frontier of Genetic Medicine: Decoding the ‘In Vivo’ vs. ‘Ex Vivo’ Divide

Shaping the Future of Genomic Medicine: ASHG Announces 2027 Leadership Appointments

• Genomics and Precision Medicine

Shaping the Future of Genomic Medicine: ASHG Announces 2027 Leadership Appointments

Nila Kartika Wati September 9, 2026

ROCKVILLE, MD — In a pivotal development for the global scientific community, the American Society of Human...

Read More Read more about Shaping the Future of Genomic Medicine: ASHG Announces 2027 Leadership Appointments

The Pink Ribbon Legacy: Elizabeth Hurley and the Three-Decade Crusade Against Breast Cancer

• Patient Advocacy and Support

The Pink Ribbon Legacy: Elizabeth Hurley and the Three-Decade Crusade Against Breast Cancer

Nila Kartika Wati September 9, 2026

Executive Summary: A Night of Philanthropy and Remembrance In a sea of vibrant fuchsia and shimmering gowns,...

Read More Read more about The Pink Ribbon Legacy: Elizabeth Hurley and the Three-Decade Crusade Against Breast Cancer

METAvivor Announces Strategic Transition to Bloomerang for Peer-to-Peer Fundraising

• Metastatic Breast Cancer Research

METAvivor Announces Strategic Transition to Bloomerang for Peer-to-Peer Fundraising

Nila Kartika Wati September 9, 2026

In an effort to streamline operations and enhance the donor experience, METAvivor, the leading non-profit organization dedicated...

Read More Read more about METAvivor Announces Strategic Transition to Bloomerang for Peer-to-Peer Fundraising

The Dawn of the Agentic Era: Schrödinger and Bristol Myers Squibb Transform Drug Discovery with Bunsen

• Treatment Innovations

The Dawn of the Agentic Era: Schrödinger and Bristol Myers Squibb Transform Drug Discovery with Bunsen

Nila Kartika Wati September 8, 2026

In a landmark development for the pharmaceutical industry, Schrödinger, the pioneer of physics-based computational drug discovery, has...

Read More Read more about The Dawn of the Agentic Era: Schrödinger and Bristol Myers Squibb Transform Drug Discovery with Bunsen